Literature DB >> 32805688

MicroRNAs in breast cancer: New maestros defining the melody.

Hoda Khalife1, Najwa Skafi2, Mohammad Fayyad-Kazan3, Bassam Badran4.   

Abstract

MicroRNAs, short non-coding single-stranded RNAs, are important regulators and gatekeepers of the coding genes in the human genome. MicroRNAs are highly conserved among species and expressed in different tissues and cell types. They are involved in almost all the biological processes as apoptosis, proliferation, cell cycle arrest and differentiation. Playing all these roles, it is not surprising that the deregulation of the microRNA profile causes a number of diseases including cancer. Breast cancer, the most commonly diagnosed malignancy in women, accounts for the highest cancer-related deaths worldwide. Different microRNAs were shown to be up or down regulated in breast cancer. MicroRNAs can function as oncogenes or tumor suppressors according to their targets. In this review, the most common microRNAs implicated in breast cancer are fully illustrated with their targets. Besides, the review highlights the effect of exosomal microRNA on breast cancer and the effect of microRNAs on drug and therapies resistance as well as the miRNA-based therapeutic strategies used until today.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; MicroRNA; Pathogenesis; Therapy

Mesh:

Substances:

Year:  2020        PMID: 32805688     DOI: 10.1016/j.cancergen.2020.08.005

Source DB:  PubMed          Journal:  Cancer Genet


  6 in total

Review 1.  Tumor reversion: a dream or a reality.

Authors:  Avantika Tripathi; Anjali Kashyap; Greesham Tripathi; Joni Yadav; Rakhi Bibban; Nikita Aggarwal; Kulbhushan Thakur; Arun Chhokar; Mohit Jadli; Ashok Kumar Sah; Yeshvandra Verma; Hatem Zayed; Amjad Husain; Alok Chandra Bharti; Manoj Kumar Kashyap
Journal:  Biomark Res       Date:  2021-05-06

2.  Prognostic nomogram for surgery of lung cancer in HIV-infected patients.

Authors:  Lin Wang; Liwei Wu; Jianjian Liu; Laiyi Wan; Hui Chen; Yijun Zhu; Jun Wang; Hongwei Li; Lei Shi; Leilei Li; Yanzheng Song
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

3.  Bioinformatics Analysis Reveals the Related Role of miR-511-5p in the Progression of Breast Cancer.

Authors:  Teng Wang; Jinquan Liu; Rui Zhong; Yidan Zhang; Zhenxuan Sun; Jutao Li; Gang Hu; Li Sun; Jintao Liu
Journal:  J Healthc Eng       Date:  2022-02-10       Impact factor: 2.682

4.  Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer.

Authors:  Rosalba Torrisi; Valentina Vaira; Laura Giordano; Annarita Destro; Vera Basilico; Saveria Mazzara; Piermario Salvini; Gabriella Gaudioso; Bethania Fernandes; Noemi Rudini; Giovanna Masci; Armando Santoro
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

5.  miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients.

Authors:  Nesreen G Elhelbawy; Ibrahim F Zaid; Aya A Khalifa; Suzy F Gohar; Eman A Fouda
Journal:  Biochem Biophys Rep       Date:  2021-06-21

Review 6.  MicroRNAs as a clue to overcome breast cancer treatment resistance.

Authors:  Iris Garrido-Cano; Birlipta Pattanayak; Anna Adam-Artigues; Ana Lameirinhas; Sandra Torres-Ruiz; Eduardo Tormo; Raimundo Cervera; Pilar Eroles
Journal:  Cancer Metastasis Rev       Date:  2021-09-15       Impact factor: 9.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.